» Articles » PMID: 21420176

Ophthalmic Antibiotics and Antimicrobial Resistance a Randomized, Controlled Study of Patients Undergoing Intravitreal Injections

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 2011 Mar 23
PMID 21420176
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine whether repeated exposure of ocular and nasopharyngeal flora to ophthalmic antibiotics promotes antimicrobial resistance in patients undergoing intravitreal injections for choroidal neovascularization (CNV).

Design: Prospective, randomized, controlled, clinical trial.

Participants: Forty-eight eyes of 24 patients undergoing unilateral intravitreal injections for CNV.

Methods: Patients were assigned randomly to 1 of 4 ophthalmic antibiotics (azithromycin 1%, ofloxacin 0.3%, gatifloxacin 0.3%, moxifloxacin 0.5%) to be used after each injection in the treatment eye only. Bilateral conjunctival and unilateral nasopharyngeal cultures on the treatment side were obtained at baseline and were repeated at each subsequent visit for 1 year. All bacterial isolates were tested for antibiotic susceptibility to 16 different antibiotics using the Kirby-Bauer disc diffusion technique. Genetic analysis of bacteria strains was performed using pulse-field gel electrophoresis.

Main Outcome Measures: Changes in antibiotic susceptibility patterns of conjunctival and nasopharyngeal flora over time and emergence of resistant strains.

Results: Eight subjects (33%) grew Staphylococcus aureus from the nasopharynx and 1 subject (13%) showed emergence of a resistant strain. Coagulase-negative staphylococci (CNS) cultured from eyes repeatedly exposed to fluoroquinolone antibiotics demonstrated significantly increased rates of resistance to third- and fourth-generation fluoroquinolones compared with untreated eyes. Resistance to ofloxacin and levofloxacin was roughly 85% (P = 0.003), and resistance to gatifloxacin and moxifloxacin approached 67% (P = 0.009) and 77% (P<0.001), respectively. In contrast, CNS isolated from eyes repeatedly exposed to azithromycin demonstrated significantly increased resistance (94%) to erythromycin and azithromycin when compared with control eyes (P = 0.009) and decreased resistance to third-generation (P<0.03) and fourth-generation (P<0.001) fluoroquinolones when compared with eyes exposed to fluoroquinolones.

Conclusions: Repeated exposure of ocular and nasopharyngeal flora to ophthalmic antibiotics selects for resistant strains.

Citing Articles

Analysis of topical conjunctival microbiotic cultures in patients treated with intravitreal injections using antibiotic prophylaxis with 0.3% ofloxacin eye drops.

de Miranda Goncalves L, Campos M, Barros G, da Veiga G, Silva J, Fonseca F Int J Retina Vitreous. 2024; 10(1):99.

PMID: 39707574 PMC: 11660893. DOI: 10.1186/s40942-024-00604-x.


Intravitreal injection practice patterns among Chinese ophthalmologists.

Su L, Shen Y, Li H, Mou B, Liu K, Xu X Int J Ophthalmol. 2024; 17(9):1717-1722.

PMID: 39296554 PMC: 11367435. DOI: 10.18240/ijo.2024.09.20.


Effects of the Dibenzofuran, Usnic Acid, on Inhibition of Ocular Biofilm Formation Due to Coagulase-Negative Staphylococci.

Kivanc S, Akova B, Kivanc M Med Sci Monit. 2023; 29:e940266.

PMID: 37073093 PMC: 10124906. DOI: 10.12659/MSM.940266.


Topical Antibiotic Prophylaxis and Intravitreal Injections: Impact on the Incidence of Acute Endophthalmitis-A Nationwide Study in France from 2009 to 2018.

Baudin F, Benzenine E, Mariet A, Ben Ghezala I, Bron A, Daien V Pharmaceutics. 2022; 14(10).

PMID: 36297568 PMC: 9611403. DOI: 10.3390/pharmaceutics14102133.


Ocular microbiota promotes pathological angiogenesis and inflammation in sterile injury-driven corneal neovascularization.

Lee H, Yoon C, Kim H, Ko J, Ryu J, Jo D Mucosal Immunol. 2022; 15(6):1350-1362.

PMID: 35986099 DOI: 10.1038/s41385-022-00555-2.